
REPLIGEN CORP
Aktie · US7599161095 · RGEN · 870980 (XNAS)
132,00 USD
11.06.2025 20:06
Aktuelle Kurse von REPLIGEN CORP
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
---|---|---|---|---|---|
![]() NASDAQ |
RGEN
|
USD
|
11.06.2025 20:06
|
132,00 USD
| 132,87 USD
-0,65 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
-0,65 % | 4,31 % | 7,11 % | -4,91 % | -13,12 % | -6,54 % | 9,99 % |
Profil de l'entreprise pour REPLIGEN CORP Action
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Données de l'entreprise
Nom REPLIGEN CORP
Société Repligen Corporation
Symbole RGEN
Site web
https://www.repligen.com
Marché d'origine
NASDAQ

WKN 870980
ISIN US7599161095
Type de titre Action
Secteur Healthcare
Industrie Medical - Instruments & Supplies
PDG Mr. Olivier Loeillot
Capitalisation boursière 7 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 1,8 T
Adresse Building 1, 02453 Waltham
Date d'introduction en bourse 1986-04-29
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | RGN.F |
NASDAQ | RGEN |
Autres actions
Les investisseurs qui détiennent REPLIGEN CORP ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.